Literature DB >> 8243490

Impact of cefpodoxime proxetil and amoxicillin on the normal oral and intestinal microflora.

B Brismar1, C Edlund, C E Nord.   

Abstract

Ten healthy volunteers were given 200 mg cefpodoxime proxetil tablets every 12 h and ten volunteers received 500 mg amoxicillin tablets every 8 h for seven days and the impact of the agents on the oral and intestinal microflora was studied. In the oral microflora, only minor alterations were observed in both groups. In subjects receiving cefpodoxime proxetil, the numbers of streptococci, enterobacteria and clostridia were strongly reduced in the faecal flora, while there was an overgrowth of enterococci, yeasts and Clostridium difficile. Amoxicillin administration induced somewhat smaller alterations in the faecal microflora, although all subjects had overgrowth of new colonizing amoxicillin resistant microorganisms, mainly Escherichia coli, Klebsiella and Enterobacter. Beta-lactamase activity was detected in the flora of six volunteers from each group.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8243490     DOI: 10.1007/bf02009388

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  7 in total

Review 1.  Impact of antimicrobial agents on human intestinal microflora.

Authors:  C E Nord; C Edlund
Journal:  J Chemother       Date:  1990-08       Impact factor: 1.714

Review 2.  A review of the pharmacokinetics of cefpodoxime proxetil.

Authors:  M T Borin
Journal:  Drugs       Date:  1991       Impact factor: 9.546

3.  Microbiological evaluation of cefpodoxime proxetil.

Authors:  B Wiedemann; E Luhmer; M T Zühlsdorf
Journal:  Drugs       Date:  1991       Impact factor: 9.546

4.  Emergence of beta-lactamase producing anaerobic bacteria in the tonsils during penicillin treatment.

Authors:  K Tunér; C E Nord
Journal:  Eur J Clin Microbiol       Date:  1986-08       Impact factor: 3.267

5.  Effect of phenoxymethylpenicillin and clindamycin on the oral, throat and faecal microflora of man.

Authors:  A Heimdahl; C E Nord
Journal:  Scand J Infect Dis       Date:  1979

6.  Antimicrobial activity and disk diffusion susceptibility testing of U-76,253A (R-3746), the active metabolite of the new cephalosporin ester, U-76,252 (CS-807).

Authors:  R N Jones; A L Barry
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

7.  Presence of Clostridium difficile and antibiotic and beta-lactamase activities in feces of volunteers treated with oral cefixime, oral cefpodoxime proxetil, or placebo.

Authors:  E Chachaty; C Depitre; N Mario; C Bourneix; P Saulnier; G Corthier; A Andremont
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

  7 in total
  11 in total

Review 1.  Cefpodoxime proxetil: a review of its use in the management of bacterial infections in paediatric patients.

Authors:  B Fulton; C M Perry
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

2.  [Antibiotic induced diarrhea and pseudomembranous colitis].

Authors:  C Greb; T Kalem; T Kälble
Journal:  Urologe A       Date:  2002-12-19       Impact factor: 0.639

3.  Identification and quantitation of cobalamin and cobalamin analogues in human feces.

Authors:  Robert H Allen; Sally P Stabler
Journal:  Am J Clin Nutr       Date:  2008-05       Impact factor: 7.045

4.  Lactobacillus reuteri and Escherichia coli in the human gut microbiota may predict weight gain associated with vancomycin treatment.

Authors:  M Million; F Thuny; E Angelakis; J-P Casalta; R Giorgi; G Habib; D Raoult
Journal:  Nutr Diabetes       Date:  2013-09-09       Impact factor: 5.097

5.  Association Between Antibiotic Exposure, Bronchiolitis, and TLR4 (rs1927911) Polymorphisms in Childhood Asthma.

Authors:  Eun Lee; Ji-Won Kwon; Hyo-Bin Kim; Ho-Sung Yu; Mi-Jin Kang; Kyungmo Hong; Song I Yang; Young Ho Jung; Seung-Hwa Lee; Kil Young Choi; Hye Lim Shin; Seo Ah Hong; Hyung Young Kim; Ju-Hee Seo; Byoung-Ju Kim; So Yeon Lee; Dae Jin Song; Woo-Kyung Kim; Gwang Cheon Jang; Jung Yeon Shim; Soo-Jong Hong
Journal:  Allergy Asthma Immunol Res       Date:  2015-01-16       Impact factor: 5.764

Review 6.  Factors Explaining Interpersonal Variation in Plasma Enterolactone Concentrations in Humans.

Authors:  Elin Hålldin; Anne Kirstine Eriksen; Carl Brunius; Andreia Bento da Silva; Maria Bronze; Kati Hanhineva; Anna-Marja Aura; Rikard Landberg
Journal:  Mol Nutr Food Res       Date:  2019-03-26       Impact factor: 5.914

Review 7.  Gut Microbiota, Antibiotic Therapy and Antimicrobial Resistance: A Narrative Review.

Authors:  Benoit Pilmis; Alban Le Monnier; Jean-Ralph Zahar
Journal:  Microorganisms       Date:  2020-02-17

Review 8.  Human gut microbiota: repertoire and variations.

Authors:  Jean-Christophe Lagier; Matthieu Million; Perrine Hugon; Fabrice Armougom; Didier Raoult
Journal:  Front Cell Infect Microbiol       Date:  2012-11-02       Impact factor: 5.293

9.  Effects of treatment with antimicrobial agents on the human colonic microflora.

Authors:  Fatemeh Rafii; John B Sutherland; Carl E Cerniglia
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

Review 10.  Role of cephalosporins in the era of Clostridium difficile infection.

Authors:  Mark H Wilcox; James D Chalmers; Carl E Nord; Jane Freeman; Emilio Bouza
Journal:  J Antimicrob Chemother       Date:  2016-09-22       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.